CRISPR/Cas9 technology generated a G to C substitution at nucleotide -1 of exon 10 (c.2146-1G>C, i.e. IVS10-1G>C in human) generating a splice acceptor site mutation. (J:326270)
查看原文 参与反馈
CRISPR/Cas9 technology generated a G to C substitution at nucleotide -1 of exon 10 (c.2146-1G>C, i.e. IVS10-1G>C in human) generating a splice acceptor site mutation. (J:326270)